RecruitingNot ApplicableNCT05215197

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

Sponsor

Pamukkale University

Enrollment

10 participants

Start Date

Jan 31, 2022

Study Type

INTERVENTIONAL

Conditions

Hearing Loss, Sensorineural

Summary

Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.

Eligibility

Inclusion Criteria2

Patients with sensorineural hearing loss
Patients who will have cochlear implant surgery with CI422 electrode

Exclusion Criteria2

Patients with cochlear abnormality
Patients with auditory neuropathy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGintracochlear platelet rich fibrin administration

intracochlear platelet rich fibrin administration during routine cochlear implantation surgery

Locations(1)

Pamukkale University

Denizli, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05215197

Related Trials

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

NCT042405612 locations

BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants

NCT0580854313 locations